JXSB2300051 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2023-05-05 | | Eli Lilly & Company | | | view |
JXSB2000014 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2020-09-17 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2020-09-16 | view |
JXSB2101069 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-10-21 | | Eli Lilly & Company | | | view |
JXSL1900014 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products | Import Drug Application | 2019-02-18 | | Eli Lilly & Company | In Review | 2019-02-16 | view |
JXSB2200083 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2022-06-20 | | Eli Lilly & Company | | | view |
JXSL2000073 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products | Import Drug Application | 2020-06-10 | | Eli Lilly & Company | In Review | 2020-06-09 | view |
JXSB2400162 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-11-29 | | Eli Lilly & Company | | | view |
JXSB2100024 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-03-19 | view |
JXSB2101033 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-07-13 | | Eli Lilly & Company | | | view |
JXSL1900094 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products | Import Drug Application | 2019-09-23 | | Eli Lilly & Company | In Review | 2019-09-21 | view |
JXSB2200110 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2022-09-06 | | Eli Lilly & Company | | | view |
JXSB2101070 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-10-21 | | Eli Lilly & Company | | | view |
JXSL2000075 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products | Import Drug Application | 2020-06-10 | | Eli Lilly & Company | In Review | 2020-06-09 | view |
JXSB2300069 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2023-06-07 | | Eli Lilly & Company | | | view |
JXSB2100023 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2021-03-19 | view |
JXSB2101110 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2021-12-16 | | Eli Lilly & Company | | | view |
JXSL1900093 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products | Import Drug Application | 2019-09-23 | | Eli Lilly & Company | In Review | 2019-09-21 | view |
JXSB2200082 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2022-06-20 | | Eli Lilly & Company | | | view |
JYSB2000240 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products | Supplementary Application | 2020-06-19 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company | In Review | 2020-06-18 | view |
JXSB2200109 | Mirikizumab注射液 | mirikizumab | Injection | Biological Products(1) | Supplementary Application | 2022-09-06 | | Eli Lilly & Company | | | view |